Ocular Changes in Vitiligo Patients on Therapy

Benha University

Status: Unknown

Conditions: Chorioretinitis; Vitiligo; Chorioretinopathy

Treatments: Diagnostic Test: Optical coherence tomography angiography (OCT-A)

Study type: Observational

Funder types: Other

Identifiers

NCT05335746

Rc 6-2022

Details and patient eligibility

About

Vitiligo patients on systemic and local therapy may have some ocular adverse effects associated with the disease and its therapy.

Full description

Chorioretinal changes associated with vitiligo therapy could address patients visual acuity and life style. Early detection of these changes can help these patients to evade such adverse effects.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• vitiligo patients on systemic and local therapy that regularly visit dermatology clinic at banha university.
• normal subjects seeking regular ophthalmic examination at ophthalmology clinic at banha university.

Exclusion criteria

• patients with known chronic retinal diseases that may alter OCT-A parameters as age related macular degeneration and diabetic retinopathies.
• patients that refuse to participate in this study.

Trial design

100 participants in 2 patient groups

Vitiligo patients on therapy

Description:

Patients diagnosed as vitiligo and on systemic and local therapy.

Treatment:

Diagnostic Test: Optical coherence tomography angiography (OCT-A)

Control group

Description:

Normal subjects recruited from ophthalmology clinic and visit the clinic for regular check-up.

Treatment:

Diagnostic Test: Optical coherence tomography angiography (OCT-A)